The decrease in albumin can reduce the protein binding rate of Linezolid in plasma and alter its distribution, leading to increased drug exposure and the occurrence of thrombocytopenia (Cattaneo et al., 2023). The gene discussed is ALB; the disease is Thrombocytopenia.